Jade Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| JBIO | CLYM | 8SJ.F | 2126.HK | DNTH | 1873.HK | |
|---|---|---|---|---|---|---|
| Market cap | 956.50M | 535.88M | 1.84B | 1.11B | 4.80B | 2.80B |
| P/E (TTM) | — | — | — | — | — | 16.9 |
| Forward P/E | -5.6 | -9.3 | — | -3.0 | -18.6 | 6.2 |
| Price/book | 2.2 | 2.2 | 2.4 | 2.0 | 7.5 | 0.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +68.04% | +378.46% | −37.59% | −31.72% | +135.55% | −43.17% |
| Today | +3.23% | −4.31% | +1.70% | +7.91% | +3.76% | +5.04% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All JBIO news ›Jade Biosciences, Inc. (NASDAQ:JBIO) Stock Has Average Target Price of $51.75
Posted by Tristan Rich on Oct 27th, 2026 Check Out Our Latest Research Report on JBIO JBIO opened at $14.50 on Tuesday. Jade Biosciences has a 52-week low of $8.36 and a 52-week high of $28.00. The firm’s fifty day simple moving average is…
Jade Biosciences presents JADE101 trial updates at ASN Kidney Week 2026
Jade Biosciences, Inc. (Nasdaq: JBIO) announced three poster presentations related to its investigational drug JADE101 at the American Society of Nephrology Kidney Week 2026, held in Denver, Colorado from October 21-25, 2026. JADE101 is an…
Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026
SCHMID Group Reaches Agreement on Significant Equipment Order to Support HDI Capacity Expansion in Malaysia INVE Technologies Announces the Commencement of a $20 Million Modified Dutch Auction Tender Offer for its Common Stock ASHFORD…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net1
- streetinsider.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.